Roux-en-Y gastric bypass for recurrent nonalcoholic steatohepatitis in liver transplant recipients with morbid obesity

Transplantation

Volumn 72, Issue 1, 2001, Pages 156-159

  Duchini, Andrea ^a   Brunson, Mathew E ^a,b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b SCRIPPS CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; LIPID; LIVER ENZYME; PREDNISONE; TACROLIMUS; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CASE REPORT; FATTY LIVER; FEMALE; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; OBESITY; PRIORITY JOURNAL; RECURRENT DISEASE; ROUX Y ANASTOMOSIS; STOMACH BYPASS;

ADULT; ANASTOMOSIS, ROUX-EN-Y; FATTY LIVER; FEMALE; GASTRIC BYPASS; HEPATITIS; HUMANS; LIVER; LIVER TRANSPLANTATION; MALE; OBESITY, MORBID; RECURRENCE;

EID: 0035879150     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200107150-00029     Document Type: Article

References (10)

1. Results of the surgical treatment of obesity
2. Recurrence of nonalcoholic steatohepatitis in a liver transplant recipient
3. Increased early morbidity and mortality with acceptable long-term function in severely obese patients undergoing liver transplantation
4. Metabolic complications of liver transplantation: Diabetes, hypercholesterolemia, hypertension and obesity
5. Liver transplantation in patients with severe obesity
6. Common medical diseases after liver transplantation
7. Cardiovascular risk factors in long-term follow-up after orthotopic liver transplantation
8. Weight change and obesity after liver transplantation: Incidence and risk factors
9. Gastric bypass in morbidly obese kidney transplant recipients
10. Improvement in heart disease risk factors after gastric bypass